Article
Surveillance of <i>in situ</i> tumor arrays reveals early environmental control of cancer immunity
2021-05-28
Abstract excerpt
<h4>Summary</h4> The immune phenotype of a tumor is a key predictor of its response to immunotherapy 1–4 . Patients who respond to immune checkpoint blockade generally present with tumors that are infiltrated by activated T cells, a tumor-immune phenotype referred to as ‘immune inflamed’ 5–7 . However, not all immune inflamed tumors respond to therapy, and in addition the majority of patients presents with tumo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c6cbda96-0901-5f8b-a2e4-56128a863975
- DOI
- 10.1101/2021.05.27.445482
